Abstract:e12028 Background: Continuous exposure of breast cancer cells to adriamycin (ADR) induces the over-expression of P-glycoprotein (P-gp) and multiple drug resistance. However, the biochemical process and underlying mechanisms are not clear. Our previous study revealed that ADR increased reactive oxygen species (ROS) generation and reduced glutathione (GSH) biosynthesis, while N-acetylcysteine, the ROS scavenger, reversed the over-expressed P-gp induced by ADR. Methods: Based on MCF-7 breast cancer cells and the adriamycin-resistant MCF-7 subline (MCF-7R), we investigated the P-gp expression on mRNA, protein and function level by qPCR, western blotting, flow cytometry and laser scanning confocal and so on, under SLC7A11 down-regulation/over-expression, cystine depletion/supplement, increased ROS generation and combined factors. Results: The present study showed that ADR inhibited cystine influx (source material of GSH) and SLC7A11 transporter (in charge of cystine uptake) in MCF-7 cells. For the first time, we showed that a down-regulation/silence of SLC7A11, or cystine deprivation, or an enhanced exposure of ROS agents directly and significantly increased P-gp expression; yet, a combination of either an inhibited/silenced SLC7A11 or cystine deprivation and an increased ROS dramatically promoted the P-gp expression in MCF-7 cells. On the contrary, an over-expression of SLC7A11, or sufficiently supplementary cystine, or scavenger of ROS significantly depressed P-gp expression and activity. Moreover, the down-regulation of SLC7A11 and cystine deprivation induced an elevation of ROS and P-gp that could be reversed by N-acetylcysteine. It was suggested that ROS and SLC7A11/cystine were the two relevant factors responsible for the upregulated expression and function of P-gp. Conclusions: This study provided the direct evidences suggesting that ROS triggered over-expression of P-gp and demonstrated that the combination of either an inhibition of SLC7A11 or cystine influx and elevated ROS was the underlying mechanism contributing to P-gp over-expression induced by ADR. It was indicated that the SLC7A11 might be a potential target modulating ADR resistance.

Overexpression of a 40-kDa protein in human multidrug resistant cells.

Annexin-I Expression Modulates Drug Resistance in Tumor Cells.

Overexpression of Survivin and XIAP in MDR Cancer Cells Unrelated to P-glycoprotein

An Investigation of Heat Shock Protein 27 and P-glycoprotein Mediated Multi-Drug Resistance in Breast Cancer Using Liquid Chromatography-Tandem Mass Spectrometry-Based Targeted Proteomics

[Expression and Clinical Significance of Mdr-1 Gene in Lymphoma].

Up‐regulation of CD147 and Matrix Metalloproteinase‐2, ‐9 Induced by P‐glycoprotein Substrates in Multidrug Resistant Breast Cancer Cells

Laptm4b: A Novel Cancer-Associated Gene Motivates Multidrug Resistance Through Efflux and Activating Pi3k/Akt Signaling

Characterization of A 95 Kilodalton Membrane Glycoprotein Associated with Multidrug-Resistance

H19 Gene Overexpression In Atypical Multidrug-Resistant Cells Associated With Expression Of A 95-Kilodalton Membrane Glycoprotein

Tumor Endothelial Expression of P-glycoprotein Upon Microvesicular Transfer of TrpC5 Derived from Adriamycin-Resistant Breast Cancer Cells.

The Underlying Mechanism Contributing to P-gp Over-Expression and Drug Resistance in the MCF-7 Breast Cancer Cells Induced by Adriamycin.

Changes in Phospholipase D Isoform Activity and Expression in Multidrug-Resistant Human Cancer Cells.

The role of P-glycoprotein/cellular prion protein interaction in multidrug-resistant breast cancer cells treated with paclitaxel

Overexpression of ATP-Binding Cassette Subfamily G Member 2 Confers Resistance to Phosphatidylinositol 3-Kinase Inhibitor PF-4989216 in Cancer Cells

The 44 Kda Pim-1 Kinase Phosphorylates BCRP/ABCG2 and Thereby Promotes Its Multimerization and Drug Resistant Activity in Human Prostate Cancer Cells

Overcoming Multidrug-Resistance in Vitro and in Vivo Using the Novel P-glycoprotein Inhibitor 1416.

Expression of P-gp, MRP, LRP, GST-π and TopoIIα and intrinsic resistance in human lung cancer cell lines.

P-Glycoprotein Overexpression is Associated with Cisplatin Resistance in Human Osteosarcoma

[CD147 and Matrix Metallo-Proteinase (MMP) 2 and MMP9 Expression in Multidrug Resistant Breast Cancer Cells Treated with P-glycoprotein Substrate Drugs].

Expression of Multidrug Resistance Gene in Human Cancers

Identification of proteins responsible for the multiple drug resistance in 5-fluorouracil-induced breast cancer cell using proteomics analysis